The FDA De Novo authorized BioFire RP2.1 Panel is a frontline test to help clinicians quickly diagnose respiratory infections, including COVID-19, influenza, RSV, and many others.

The BIOFIRE RP2.1 Panel is a frontline test to help clinicians more quickly diagnose URTIs, including COVID-19, influenza, RSV, and many others. The multiplex PCR panel identifies 22 pathogen …

The BioFire Respiratory 2.1 Panel (RP2.1) is a multiplex polymerase chain reaction (PCR) test that identifies nucleic acids from 23 difer-ent bacteria and viruses that commonly cause upper and...

This article provides a comprehensive, clinician-friendly explanation of the BioFire Test, including how it works, available panels, clinical indications, advantages, limitations, and its growing role in evidence …

The BIOFIRE System is the new standard for syndromic infectious disease diagnostics. Simple, fast, and comprehensive, the BIOFIRE System delivers accurate results in about one hour.

Dec 22, 2020 · The BioFire RP2.1 is a molecular (PCR) test authorized for use on respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. This Fact Sheet …

The SPOTFIRE R/ST Panels bring PCR diagnostics closer to patients, testing for a broad grouping of probable respiratory and sore throat pathogens into one rapid test. The panels’ versatility may …

Designed with the syndromic approach in mind, each panel can detect a broad grouping of probable pathogenic causes in a single, rapid test. The BioFire Panels test for viruses, bacteria, parasites, …

May 24, 2022 · The EUA (Emergency Use Authorization) for the BioFire COVID-19 Test enables CLIA moderate and high complexity laboratories to conduct a PCR test for SARS-CoV-2 in-house, …

The BioFire Respiratory Panel 2.1-EZ (RP2.1-EZ) is a multiplexed polymerase chain reaction (PCR) test authorized for use with nasopharyngeal swab specimens obtained from individuals suspected...